Bruce A. Mueller

7.1k total citations · 1 hit paper
160 papers, 4.8k citations indexed

About

Bruce A. Mueller is a scholar working on Pharmacology, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Bruce A. Mueller has authored 160 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pharmacology, 62 papers in Nephrology and 26 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Bruce A. Mueller's work include Antibiotics Pharmacokinetics and Efficacy (66 papers), Acute Kidney Injury Research (40 papers) and Dialysis and Renal Disease Management (36 papers). Bruce A. Mueller is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (66 papers), Acute Kidney Injury Research (40 papers) and Dialysis and Renal Disease Management (36 papers). Bruce A. Mueller collaborates with scholars based in United States, Senegal and Egypt. Bruce A. Mueller's co-authors include William L. Macias, Deborah A. Pasko, Manjunath P. Pai, William R. Clark, Kevin M. Sowinski, Keith A. Rodvold, Mariann D. Churchwell, Thomas P. Lodise, Meri K. Scott and Annie Wong‐Beringer and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Bruce A. Mueller

156 papers receiving 4.6k citations

Hit Papers

Therapeutic monitoring of vancomycin for serious methicil... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce A. Mueller United States 34 2.1k 1.6k 1.1k 807 580 160 4.8k
Gary R. Matzke United States 34 1.5k 0.7× 673 0.4× 683 0.6× 640 0.8× 298 0.5× 147 4.2k
Roger W. Jelliffe United States 39 2.1k 1.0× 397 0.2× 1.2k 1.1× 1.2k 1.5× 338 0.6× 148 5.0k
Andrew Udy Australia 38 3.2k 1.5× 983 0.6× 905 0.8× 2.6k 3.2× 641 1.1× 215 6.5k
Dario Cattaneo Italy 38 714 0.3× 637 0.4× 1.6k 1.4× 810 1.0× 263 0.5× 233 5.8k
Jacobus Ungerer Australia 37 1.6k 0.7× 556 0.3× 346 0.3× 1.1k 1.4× 296 0.5× 168 4.6k
Brett McWhinney Australia 37 1.7k 0.8× 520 0.3× 314 0.3× 1.0k 1.3× 321 0.6× 143 4.5k
Thomas A. Golper United States 40 653 0.3× 3.5k 2.1× 369 0.3× 476 0.6× 354 0.6× 144 5.7k
Henry Gault Canada 13 1.6k 0.8× 3.8k 2.3× 972 0.8× 1.7k 2.2× 424 0.7× 22 12.8k
Alexander A. Vinks United States 48 2.8k 1.3× 441 0.3× 767 0.7× 1.7k 2.1× 449 0.8× 288 8.5k
Christian Joukhadar Austria 40 1.9k 0.9× 233 0.1× 1.0k 0.9× 1.3k 1.7× 632 1.1× 100 4.4k

Countries citing papers authored by Bruce A. Mueller

Since Specialization
Citations

This map shows the geographic impact of Bruce A. Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce A. Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce A. Mueller more than expected).

Fields of papers citing papers by Bruce A. Mueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce A. Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce A. Mueller. The network helps show where Bruce A. Mueller may publish in the future.

Co-authorship network of co-authors of Bruce A. Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce A. Mueller. A scholar is included among the top collaborators of Bruce A. Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce A. Mueller. Bruce A. Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shujun, Bruce A. Mueller, Z. Wang, et al.. (2024). 486P Effects of a BBB-penetrating oligonucleotide drug, RBD8088, in mouse models of human glioblastoma. Annals of Oncology. 35. S422–S422.
2.
Mueller, Bruce A., et al.. (2024). Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future Directions. Blood Purification. 53(6). 520–526.
3.
Rybak, Michael J., Jennifer Lê, Thomas P. Lodise, et al.. (2020). Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. American Journal of Health-System Pharmacy. 77(11). 835–864. 702 indexed citations breakdown →
4.
Segal, Jonathan H., Noha N. Salama, Michael Heung, et al.. (2019). Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis. Renal Failure. 41(1). 118–125. 2 indexed citations
5.
Nigwekar, Sagar U., et al.. (2019). Impact of hemodialysis on the concentrations of sodium and potassium during infusion of sodium thiosulfate using an In Vitro hemodialysis model. PLoS ONE. 14(11). e0224767–e0224767. 1 indexed citations
6.
Murthy, Venkatesh L., et al.. (2016). Influence of hemodialysis on regadenoson clearance in an in vitro hemodialysis model. Journal of Nuclear Cardiology. 25(1). 234–239. 4 indexed citations
7.
Jamal, Janattul‐Ain, Bruce A. Mueller, Gordon Choi, Jeffrey Lipman, & Jason A. Roberts. (2015). How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?. Diagnostic Microbiology and Infectious Disease. 82(1). 92–103. 57 indexed citations
8.
Lewis, Susan J., et al.. (2015). Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy. Blood Purification. 40(1). 66–71. 22 indexed citations
9.
Mueller, Bruce A., et al.. (2012). Medication Dosing in Critically Ill Patients With Acute Kidney Injury Treated With Renal Replacement Therapy. American Journal of Kidney Diseases. 61(3). 490–500. 25 indexed citations
10.
Vilay, A. Mary, Daryl D. DePestel, Kevin M. Sowinski, et al.. (2010). Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Critical Care Medicine. 39(1). 19–25. 65 indexed citations
11.
Vilay, A. Mary, et al.. (2010). Modeled Dalbavancin Transmembrane Clearance during Intermittent and Continuous Renal Replacement Therapies. Blood Purification. 30(1). 37–43. 16 indexed citations
12.
Pasko, Deborah A., et al.. (2009). Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case series. Pediatric Nephrology. 24(4). 807–813. 24 indexed citations
13.
Fleming, Geoffrey M., Noha N. Salama, Saada Eid, Kenneth R. Cooke, & Bruce A. Mueller. (2009). Etanercept Clearance during an in vitro Model of Continuous Venovenous Hemofiltration. Blood Purification. 28(4). 348–353. 2 indexed citations
14.
Aronoff, George R., William M. Bennett, Jeffrey S. Berns, et al.. (2007). Drug prescribing in renal failure : dosing guidelines for adults and children. 133 indexed citations
15.
Sowinski, Kevin M., Steven R. Abel, William R. Clark, & Bruce A. Mueller. (1999). Effect of Gender on the Pharmacokinetics of Ofloxacin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(4). 442–446. 17 indexed citations
16.
Trujillo, Tate N., Kevin M. Sowinski, Richard A. Venezia, Meri K. Scott, & Bruce A. Mueller. (1999). Vancomycin assay performance in patients with acute renal failure. Intensive Care Medicine. 25(11). 1291–1296. 10 indexed citations
17.
Ndiaye, Ousmane, et al.. (1997). [Newborn infant with macrosomia: etiologic factors and perinatal complications].. PubMed. 42(2). 159–61. 3 indexed citations
18.
Scott, Meri K., William L. Macias, Michael A. Kraus, et al.. (1997). Effects of Dialysis Membrane on Intradialytic Vancomycin Administration. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(2). 256–262. 25 indexed citations
19.
Brophy, Donald F. & Bruce A. Mueller. (1997). Automated Peritoneal Dialysis: New Implications for Pharmacists. Annals of Pharmacotherapy. 31(6). 756–764. 5 indexed citations
20.
Mueller, Bruce A., Robert L. Talbert, Charles H. Tegeler, & Thomas J. Prihoda. (1991). The Bleeding Time Effects of a Single Dose of Aspirin in Subjects Receiving Omega‐3 Fatty Acid Dietary Supplementation. The Journal of Clinical Pharmacology. 31(2). 185–190. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026